According to the American Heart Association, scientific research supports the view that losing an hour of much needed sleep may not be the only thing to dread about “springing forward” when clocks move up for daylight saving time later this month.
News | Heart Failure
Biological Clock Shock? “Springing Forward” May Have Drawbacks For Heart Health
March 9, 2022 – According to the American Heart Association, scientific research supports the view that losing an hour ...
Home March 09, 2022
Home
The University of Maryland Medical Center has announced that David Bennett, the 57-year old patient with terminal heart disease who made history as the first person to receive a genetically modified pig’s heart, passed away yesterday afternoon on March 8.
Feature | Heart Failure
David Bennett, Pig Heart Transplant Patient, Dies

The University of Maryland Medical Center has announced that David Bennett, the 57-year old patient with terminal heart ...

Home March 09, 2022
Home
Fujifilm Sonosite, Inc., a world leader in point-of-care ultrasound (POCUS) solutions today announced it has filed a patent infringement lawsuit against Butterfly Network in the United States District Court for the District of Delaware.
News | Point-of-Care Ultrasound (POCUS)
Fujifilm Sonosite Files Patent Infringement Lawsuit Against Butterfly Network

March 9, 2022 — Fujifilm Sonosite, Inc., a world leader in point-of-care ultrasound (POCUS) solutions today announced it ...

Home March 09, 2022
Home
Vitals Xchange is a cloud-based healthcare software that seamlessly connects with PointClickCare’s full-continuum platform which utilizes Emergency Medical Records (EMR) technology to streamline patient data transmission and analysis for various healthcare facilities.
News | ECG Monitoring Services
CardioTech Announces Partnership with VitalsXchange

March 8, 2022 – Vitals Xchange is a cloud-based healthcare software that seamlessly connects with PointClickCare’s full ...

Home March 08, 2022
Home
MemorialCare Heart & Vascular Institute (MHVI), through its advanced research program, is participating in a CSL Behring-sponsored multi-center, Phase III clinical trial – "ApoA-I Event reducinG in Ischemic Syndromes II (AEGIS-II) – which is studying the removal of cholesterol from the arteries to reduce the risk of a second heart attack or stroke in patients.
News | Heart Failure
MemorialCare Heart and Vascular Institute Participating in Global Study of CSL112 in Patients with Acute Coronary Syndrome (AEGIS-II)
March 8, 2022 – MemorialCare Heart & Vascular Institute (MHVI), through its advanced research program, is participating ...
Home March 08, 2022
Home
James de Lemos, M.D.
News | Heart Failure
Addressing the Difficulty of Diagnosing Heart Attacks After Heart Surgery
Mrach 8, 2022 – Diagnosing heart attacks after heart surgery remains difficult due to shortcomings of current diagnostic ...
Home March 08, 2022
Home
AdvaMed is saddened to share that a beloved member of the AdvaMed family, Wendy Siminski, Senior Vice President of Conferences and Events, has passed away after a brave battle with breast cancer.
News | Cardiovascular Business
AdvaMed Mourns the Passing of Wendy Siminski

March 7, 2022 — AdvaMed is saddened to share that a beloved member of the AdvaMed family, Wendy Siminski, Senior Vice ...

Home March 07, 2022
Home
In January, The University of Maryland School of Medicine (UMSOM) and the University of Maryland Medical Center (UMMC) successfully executed a groundbreaking porcine heart transplant procedure in a human. This was the first successful transplant of a genetically modified pig’s heart into a human patient.
Feature | Cardiovascular Business | By Melinda Taschetta-Millane
DAIC’s Top 10 for the Month of February

Here is what you and your colleagues found to be most interesting in the field of cardiology during the month of ...

Home March 04, 2022
Home
NewAmsterdam Pharma (NAP), a clinical-stage company focused on the research and development of transformative therapies for cardiometabolic diseases, today announced dose administration for the first patient in its PREVAIL study, a global Phase 3 cardiovascular outcomes trial of the novel cholesteryl ester transfer protein (CETP) inhibitor obicetrapib
News | Heart Failure
NewAmsterdam Pharma Doses First Patient in its PREVAIL Study
March 4, 2022 – NewAmsterdam Pharma (NAP), a clinical-stage company focused on the research and development of ...
Home March 04, 2022
Home
CIRCA S-CATH M esophageal temperature probe
News | EP Mapping and Imaging Systems
CIRCA Scientific Receives FDA Clearance for New Esophageal Temperature Probe

March 3, 2022 – CIRCA Scientific, Inc. has announced that its S-CATH M Esophageal Temperature Probe is now cleared for ...

Home March 03, 2022
Home
Spontaneous coronary artery dissection (SCAD), a tear in an artery supplying blood to the heart, is a common cause of serious or fatal heart attacks that occur in women under age 50.
News | Heart Failure
Common Cause of Heart Attacks in Younger Adults Linked to Gene Variants
March 3, 2022 – Spontaneous coronary artery dissection (SCAD), a tear in an artery supplying blood to the heart, is a ...
Home March 03, 2022
Home
The University of Maryland School of Medicine’s Institute of Human Virology, a Global Virus Network (GVN) Center of Excellence, physician researchers played a collaborative role in last month’s successful transplant of a genetically-modified pig heart into a patient with terminal heart disease by creating pathogen surveillance strategies and developing an infection prevention strategy for this unprecedent significant medical advancement.
News | Heart Failure
Experts Perform Pathogen Surveillance for Unprecedented Pig-to-Human Heart Transplant
March 3, 2022 – The University of Maryland School of Medicine’s Institute of Human Virology, a Global Virus Network (GVN ...
Home March 03, 2022
Home
As 1-year-old SaRyia Moore and her family celebrate American Heart Month, they do so will full, grateful hearts — including SaRyia's transplanted heart she received just eight weeks ago, saving her young life.
News | Pediatric Cardiology
Texas Children's Hospital Passes Milestones of More Than 500 Heart Transplants, 2,000 Solid Organ Transplants
March 2, 2022 – As 1-year-old SaRyia Moore and her family celebrate American Heart Month, they do so will full, grateful ...
Home March 02, 2022
Home
John Farquhar
News | Cardiovascular Business
HeartFlow Announces CEO Transition

March 2, 2022 – HeartFlow, Inc. has announced that John Farquhar has been appointed President and Chief Executive ...

Home March 02, 2022
Home
An international study led by a researcher from Tel Aviv University offers a novel technology that can assist many patients implanted with bioprosthetic heart valve by avoiding additional complicated replacement surgery.
News | Heart Valve Technology
Novel Technology Could Prevent Repeat Operations to Replace a Faulty Bioprosthetic Heart Valve
March 2, 2022 – An international study led by a researcher from Tel Aviv University offers a novel technology that can ...
Home March 02, 2022
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now